Ardelyx

-$0.06 (-5.56%) Today
+$0.02 (+1.96%) As of 12:00 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Ardelyx and other ETFs, options, and stocks.

About ARDX

Ardelyx, Inc. is a biopharmaceutical company, which engages in the research, development and commercialization of medicine for the treatment of cardiorenal diseases. Its product portfolio includes tenapanor, which is an experimental medication that works exclusively in the gut and is in late-stage clinical development.

CEO
Michael G. Raab
Employees
129
Headquarters
Fremont, California
Founded
2007

ARDX Key Statistics

Market Cap
105.18M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.70M
High Today
$1.08
Low Today
$1.01
Open Price
$1.08
Volume
6.11M
52 Week High
$9.23
52 Week Low
$1.01

ARDX News

Simply Wall StOct 14

Insiders may be rethinking their US$1.0m Ardelyx, Inc. investment now that the company has lost US$19m in value

The recent 14% drop in Ardelyx, Inc.'s ( ) stock could come as a blow to insiders who purchased US$1.0m worth of stock at an average buy price of US$5.89 over t
MarketWatchOct 13

Ardelyx Cuts Staff After Drug-Development Setback

By Matt Grossman Ardelyx Inc. will reduce its workforce to cut costs after a meeting with the U.S. Food and Drug Administration failed to clarify a path forwar

ARDX Earnings

-$0.45
-$0.30
-$0.15
-$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure